Transitional Treatment of Adolescents in Family Therapy

NCT ID: NCT00680381

Last Updated: 2014-08-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-31

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Abuse

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Following 12 weeks of Functional Family Therapy (FFT), semi-weekly therapist phone calls for eight weeks.

Group Type ACTIVE_COMPARATOR

MTI, Minimal Transitional Intervention

Intervention Type BEHAVIORAL

Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.

2

Following 12 weeks of FFT, weekly one-hour group therapy for eight weeks

Group Type ACTIVE_COMPARATOR

GTI, Group Transitional Intervention

Intervention Type BEHAVIORAL

Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.

3

Following 12 weeks of FFT, an eight-week, customized series of therapist visits with the adolescent, family, teachers, coaches and others who can support the adolescent's reduced level of drug use.

Group Type ACTIVE_COMPARATOR

STI, Systems Transitions Intervention

Intervention Type BEHAVIORAL

Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MTI, Minimal Transitional Intervention

Following 12 weeks of Functional Family Therapy (FFT), semi-weekly phone calls from a therapist for eight weeks.

Intervention Type BEHAVIORAL

GTI, Group Transitional Intervention

Following 12 weeks of FFT, weekly one-hour sessions of group therapy for eight weeks.

Intervention Type BEHAVIORAL

STI, Systems Transitions Intervention

Following 12 weeks of FFT, an individualized eight-week series of therapist meetings with the adolescent, family, police, teachers, coaches and others who can support the adolescent's reduced drug use.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. At least one parent, step-parent, or surrogate parent willing to participate in the study
2. 13 to 18 years if age
3. meets DSM-IV (APA, 1994) diagnostic criteria for substance abuse or dependence
4. Lives in the Albuquerque metropolitan area or surrounding communities with a parent, step-parent, or surrogate parent; AND
5. Sufficient residential stability to permit probable contact at follow-up (e.g., not homeless at time of intake).

Exclusion Criteria

1. Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
2. Adolescent deemed dangerous to self or others during evaluation
3. Services other than outpatient treatment required for the adolescent (e.g., inpatient, detoxification)
4. Adolescent already has participated in treatment project at CFAR; AND
5. A sibling is already participating in project.
Minimum Eligible Age

13 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oregon Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Holly B. Waldron, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Oregon Research Institute Center for Family and Adolescent Research (ORI/CFAR)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oregon Res. Inst. Center for Family & Adolescent Research (CFAR)

Albuquerque, New Mexico, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA015762

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DA15762

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.